Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.